APA (7th ed.) Citation

Riemer, J. D., Groff, M., Raad, A., Purser, M., SAMYSHKIN, Y., & Zhang, S. (2025). EE157 Cost-Effectiveness Analysis of Momelotinib for the Treatment of Adult Patients With Myelofibrosis and Anemia in Canada. Value in Health, 28(6), S90. https://doi.org/10.1016/j.jval.2025.04.449

Chicago Style (17th ed.) Citation

Riemer, Justin D., Michael Groff, Angie Raad, Molly Purser, Yevgeniy SAMYSHKIN, and Shiyuan Zhang. "EE157 Cost-Effectiveness Analysis of Momelotinib for the Treatment of Adult Patients With Myelofibrosis and Anemia in Canada." Value in Health 28, no. 6 (2025): S90. https://doi.org/10.1016/j.jval.2025.04.449.

MLA (9th ed.) Citation

Riemer, Justin D., et al. "EE157 Cost-Effectiveness Analysis of Momelotinib for the Treatment of Adult Patients With Myelofibrosis and Anemia in Canada." Value in Health, vol. 28, no. 6, 2025, p. S90, https://doi.org/10.1016/j.jval.2025.04.449.